A new study published in the European Heart Journal has found that patients who have experienced a heart attack (myocardial ...

EHM allografts restore heart muscle safely, offering a breakthrough in heart failure treatment with no arrhythmia risk.

For Heart Health Month, Amy Ahnert, MD, discussed the link between cardiovascular disease and breast cancer.

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...

Optim Medical Center–Screven in Sylvania was honored with the prestigious Patient Safety and Quality Award at the Georgia ...

Amgen (NASDAQ:AMGN – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on ...

Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...